IT

Podcast Sponsor: Ingenuity - iReport, the fastest and most accurate way to get biological meaning from your expression data. www.ingenuity.com/get iReport/

Guest:

Don Jones, Vice President, Global Strategy and Market Development Qualcomm Life Bio and Contact Info

Listen (3:14) Why talk to Qualcomm on a life science media site?

Listen (2:32) What apps most excite you?

Listen (2:33) Consumers rather than patients

Listen (5:07) Qualcomm employee programs

Listen (5:44) Wireless can help us change our habits

Listen (1:34) Qualcomm as investor

Listen (1:54) The FDA challenge

Listen (3:45) Personal journey to wireless health

Listen (4:28) How do you currently interact with your doctor?

Every time you make a call on your cell phone, you’re using technology from Qualcomm. Now the chip maker is getting involved in healthcare. Don Jones, VP of global strategy and market development in wireless health, at Qualcomm is on a mission to bring wireless technologies to health and life sciences markets.

Jones was a founding board member of the West Wireless Health Institute, with Eric Topol and Gary and Mary West. It’s the world’s first and foremost Institute focused on the clinical efficacy and economic efficiencies of wireless technologies in healthcare. He founded Wireless Life Sciences Alliance, a local trade group based in San Diego.

Don shares his vision for where health is going in a world where more people have cell phones than have access to clean drinking water.

Podcast brought to you by: Assay Depot - the world's largest cloud-based marketplace for research services. With Assay Depot, you can easily find the perfect research service provider and manage your project from anywhere in the world.

Guest:

Katherine Holland, Global General Manager, Life Sciences, IBM Bio and Contact Info

Listen (9:50) How is IBM making a difference in the life sciences?

Listen (4:36) IBM's own transformation story

Listen (4:22) Pharma must go from product to service based model

Listen (6:41) Life science companies will interact more and more with "the consumer"

Listen (2:22) Personal path to IBM

Listen (6:33) Leveraging experience in other industries

In the mid-90's IBM came perilously close to running out of cash before transforming from a product based business (remember the unsuccessful OS/2?) to a service based model. It's one of the biggest turn-around stories of our generation. Katherine Holland is IBM's VP for Global Life Sciences, and she thinks there's a lesson or two for pharma and other life science companies in her company's story. Join us as she tells of IBM's transformation and shares her thoughts on future imperatives for the life sciences.

Guest:

Sultan Meghji, VP Product Strategy, Appistry Bio and Contact Info

Podcast Sponsor: Ingenuity - iReport, the fastest and most accurate way to get biological meaning from your expression data. Upload your data and get a free iReport analysis summary at www.ingenuity.com/get iReport/

Listen (3:01) Formative years with geneticist father

Listen (4:55) Appistry, new to life science

Listen (7:17) Regulation and security issues

Listen (4:43) Roche move on Illumina

Listen (7:26) We haven't scratched the surface of genomics

Listen (8:12) Human de novo sequencing

Listen (0:46) Emerging sequencing technologies

Listen (6:24) Sequencing still the bottleneck, not analysis

Listen (1:53) No more blockbuster drugs

Sultan Meghji is the Vice President of Product Strategy at Appistry, a company working to develop the infrastructure needed to deliver medically actionable genetic data that can be applied to individual patients. Meghji has spent more than 20 years studying the technical aspects and business applications of high performance computing. He started his career at the National Center for Supercomputing Applications (NCSA), where he developed artificial intelligence systems and Internet technologies. From there, Meghji moved into several IT leadership positions at ABN AMRO, American Express, Monsanto, United Airlines, as well as in academia.

Podcast Sponsor: AMIA - Register for AMIA’s Joint Summits on Translational Science, taking place March 19-23, in San Francisco.

Guest:

Frank Schacherer, CTO, BIOBASE Bio and Contact Info

Listen (4:12) Products and databases

Listen (1:32) Over 70 curators on staff

Listen (4:42) Why go to BIOBASE over public databases?

Listen (2:40) Customers don't have to be bioinformaticians

Listen (5:46) Example of clinical project

Listen (7:03) Where is the field at now?

Listen (3:40) A lot of human work involved

Listen (8:41) Lots of requests from clinics, but genomic medicine not routine

Listen (1:50) In school couldn't study informatics and biology at the same time

Frank Schacherer is the CTO of BIOBASE, a company headquartered near Hannover, Germany which provides a genomics data analysis service. Their product is built on a vast comprehensive database and super powerful algorithms. These are combined into a user interface for over 600 customers including pharma, clinical and academic researchers.